You are viewing a free limited preview of Aerie Pharmaceuticals, Inc.
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access

Aerie Pharmaceuticals, Inc.

Private Company Ticker Symbol™: (AERPHAP)

Business Summary

Aerie Pharmaceuticals is a privately held, clinical-stage biotechnology company dedicated to the discovery and development of novel treatments for glaucoma. All technology of the company is based on internal discovery R&D and is protected by a strong IP portfolio. The US-based company is located in Bridgewater, NJ and in Research Triangle Park, NC. Investors in Aerie are TPG Biotech, Alta Partners, Clarus Ventures, Sofinnova Ventures and Osage University Partners.

Overview & Corporate Organization

Basic Information

Company Tags:VC Backed
Year Founded:2005
Fiscal Year End:12/31
City:Bridgewater
State/Province:New Jersey
Country:United States
Phone:View
Fax:View
Website:www.aeriepharma.com

Corporate Organization

Founders:
Casey Kopczynski
David Epstein
Eric Toone

Industry Information

Industry Codes

PICS™:700803™, 1500105
NAICS:View
SIC:View

The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.

VC/Funding Activity

PrivCo's VC/Funding Activity table for Aerie Pharmaceuticals, Inc. displays the venture capital rounds, angel investments, debt or other funding raised by Aerie Pharmaceuticals, Inc..
All data before 2006 is completely free to view! To access data from 2006 onward:
Get Full Access To This Report Now! $99 Single Company Access
 
or Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!
DateInvestorRoundInvestor Type
Mar. 2011ViewBVenture Capital
Mar. 2011ViewBVenture Capital
Mar. 2011ViewBVenture Capital
Mar. 2011ViewBVenture Capital
Mar. 2011ViewBVenture Capital
DetailsTotal Round B View
Total of Funding Shown Above View

Missing a deal? Tell us about it! tips@privco.com

Supplemental Resources

For additional information on Aerie Pharmaceuticals, Inc., you can see the following:

You are viewing a free limited preview of Aerie Pharmaceuticals, Inc.
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access